- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Acne Vulgaris Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Acne Vulgaris Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinic accounting for % of the Acne Vulgaris Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CB-0601 segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Acne Vulgaris Treatment include Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, and Ensol Biosciences Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Acne Vulgaris Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others
Market segment by Application, can be divided into
Clinic
Hospital
Others
Market segment by players, this report covers
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Acne Vulgaris Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Acne Vulgaris Treatment, with revenue, gross margin and global market share of Acne Vulgaris Treatment from 2019 to 2022.
Chapter 3, the Acne Vulgaris Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Acne Vulgaris Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Acne Vulgaris Treatment research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Acne Vulgaris Treatment
1.2 Classification of Acne Vulgaris Treatment by Type
1.2.1 Overview: Global Acne Vulgaris Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Acne Vulgaris Treatment Revenue Market Share by Type in 2021
1.2.3 CB-0601
1.2.4 CJM-112
1.2.5 CLS-007
1.2.6 Dapsone
1.2.7 DFD-10
1.2.8 DLX-2323
1.2.9 Others
1.3 Global Acne Vulgaris Treatment Market by Application
1.3.1 Overview: Global Acne Vulgaris Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Acne Vulgaris Treatment Market Size & Forecast
1.5 Global Acne Vulgaris Treatment Market Size and Forecast by Region
1.5.1 Global Acne Vulgaris Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Acne Vulgaris Treatment Market Size by Region, (2017-2022)
1.5.3 North America Acne Vulgaris Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Acne Vulgaris Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Acne Vulgaris Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Acne Vulgaris Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Acne Vulgaris Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Acne Vulgaris Treatment Market Drivers
1.6.2 Acne Vulgaris Treatment Market Restraints
1.6.3 Acne Vulgaris Treatment Trends Analysis
2 Company Profiles
2.1 Common Pharma Inc
2.1.1 Common Pharma Inc Details
2.1.2 Common Pharma Inc Major Business
2.1.3 Common Pharma Inc Acne Vulgaris Treatment Product and Solutions
2.1.4 Common Pharma Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Common Pharma Inc Recent Developments and Future Plans
2.2 Cutanea Life Sciences Inc
2.2.1 Cutanea Life Sciences Inc Details
2.2.2 Cutanea Life Sciences Inc Major Business
2.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Product and Solutions
2.2.4 Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Cutanea Life Sciences Inc Recent Developments and Future Plans
2.3 Dermira Inc
2.3.1 Dermira Inc Details
2.3.2 Dermira Inc Major Business
2.3.3 Dermira Inc Acne Vulgaris Treatment Product and Solutions
2.3.4 Dermira Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Dermira Inc Recent Developments and Future Plans
2.4 ELORAC Inc
2.4.1 ELORAC Inc Details
2.4.2 ELORAC Inc Major Business
2.4.3 ELORAC Inc Acne Vulgaris Treatment Product and Solutions
2.4.4 ELORAC Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 ELORAC Inc Recent Developments and Future Plans
2.5 Ensol Biosciences Inc
2.5.1 Ensol Biosciences Inc Details
2.5.2 Ensol Biosciences Inc Major Business
2.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Product and Solutions
2.5.4 Ensol Biosciences Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Ensol Biosciences Inc Recent Developments and Future Plans
2.6 Foamix Pharmaceuticals Ltd
2.6.1 Foamix Pharmaceuticals Ltd Details
2.6.2 Foamix Pharmaceuticals Ltd Major Business
2.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product and Solutions
2.6.4 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Foamix Pharmaceuticals Ltd Recent Developments and Future Plans
2.7 Galderma SA
2.7.1 Galderma SA Details
2.7.2 Galderma SA Major Business
2.7.3 Galderma SA Acne Vulgaris Treatment Product and Solutions
2.7.4 Galderma SA Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Galderma SA Recent Developments and Future Plans
2.8 GlaxoSmithKline Plc
2.8.1 GlaxoSmithKline Plc Details
2.8.2 GlaxoSmithKline Plc Major Business
2.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Product and Solutions
2.8.4 GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 GlaxoSmithKline Plc Recent Developments and Future Plans
2.9 Helix BioMedix Inc
2.9.1 Helix BioMedix Inc Details
2.9.2 Helix BioMedix Inc Major Business
2.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Product and Solutions
2.9.4 Helix BioMedix Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Helix BioMedix Inc Recent Developments and Future Plans
2.10 Hovione FarmaCiencia SA
2.10.1 Hovione FarmaCiencia SA Details
2.10.2 Hovione FarmaCiencia SA Major Business
2.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Product and Solutions
2.10.4 Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Hovione FarmaCiencia SA Recent Developments and Future Plans
2.11 Lee's Pharmaceutical Holdings Ltd
2.11.1 Lee's Pharmaceutical Holdings Ltd Details
2.11.2 Lee's Pharmaceutical Holdings Ltd Major Business
2.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product and Solutions
2.11.4 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Lee's Pharmaceutical Holdings Ltd Recent Developments and Future Plans
2.12 LEO Pharma A/S
2.12.1 LEO Pharma A/S Details
2.12.2 LEO Pharma A/S Major Business
2.12.3 LEO Pharma A/S Acne Vulgaris Treatment Product and Solutions
2.12.4 LEO Pharma A/S Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 LEO Pharma A/S Recent Developments and Future Plans
2.13 Novabiotics Ltd
2.13.1 Novabiotics Ltd Details
2.13.2 Novabiotics Ltd Major Business
2.13.3 Novabiotics Ltd Acne Vulgaris Treatment Product and Solutions
2.13.4 Novabiotics Ltd Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Novabiotics Ltd Recent Developments and Future Plans
2.14 Novan Inc
2.14.1 Novan Inc Details
2.14.2 Novan Inc Major Business
2.14.3 Novan Inc Acne Vulgaris Treatment Product and Solutions
2.14.4 Novan Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Novan Inc Recent Developments and Future Plans
2.15 Novartis AG
2.15.1 Novartis AG Details
2.15.2 Novartis AG Major Business
2.15.3 Novartis AG Acne Vulgaris Treatment Product and Solutions
2.15.4 Novartis AG Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Novartis AG Recent Developments and Future Plans
2.16 Paratek Pharmaceuticals Inc
2.16.1 Paratek Pharmaceuticals Inc Details
2.16.2 Paratek Pharmaceuticals Inc Major Business
2.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product and Solutions
2.16.4 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Paratek Pharmaceuticals Inc Recent Developments and Future Plans
2.17 Pfizer Inc
2.17.1 Pfizer Inc Details
2.17.2 Pfizer Inc Major Business
2.17.3 Pfizer Inc Acne Vulgaris Treatment Product and Solutions
2.17.4 Pfizer Inc Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Pfizer Inc Recent Developments and Future Plans
2.18 Phosphagenics Ltd
2.18.1 Phosphagenics Ltd Details
2.18.2 Phosphagenics Ltd Major Business
2.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Product and Solutions
2.18.4 Phosphagenics Ltd Acne Vulgaris Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Phosphagenics Ltd Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Acne Vulgaris Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Acne Vulgaris Treatment Players Market Share in 2021
3.2.2 Top 10 Acne Vulgaris Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Acne Vulgaris Treatment Players Head Office, Products and Services Provided
3.4 Acne Vulgaris Treatment Mergers & Acquisitions
3.5 Acne Vulgaris Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Acne Vulgaris Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Acne Vulgaris Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Acne Vulgaris Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Acne Vulgaris Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Acne Vulgaris Treatment Revenue by Type (2017-2028)
6.2 North America Acne Vulgaris Treatment Revenue by Application (2017-2028)
6.3 North America Acne Vulgaris Treatment Market Size by Country
6.3.1 North America Acne Vulgaris Treatment Revenue by Country (2017-2028)
6.3.2 United States Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Acne Vulgaris Treatment Revenue by Type (2017-2028)
7.2 Europe Acne Vulgaris Treatment Revenue by Application (2017-2028)
7.3 Europe Acne Vulgaris Treatment Market Size by Country
7.3.1 Europe Acne Vulgaris Treatment Revenue by Country (2017-2028)
7.3.2 Germany Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
7.3.3 France Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Acne Vulgaris Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Acne Vulgaris Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Acne Vulgaris Treatment Market Size by Region
8.3.1 Asia-Pacific Acne Vulgaris Treatment Revenue by Region (2017-2028)
8.3.2 China Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
8.3.5 India Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Acne Vulgaris Treatment Revenue by Type (2017-2028)
9.2 South America Acne Vulgaris Treatment Revenue by Application (2017-2028)
9.3 South America Acne Vulgaris Treatment Market Size by Country
9.3.1 South America Acne Vulgaris Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Acne Vulgaris Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Acne Vulgaris Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Acne Vulgaris Treatment Market Size by Country
10.3.1 Middle East & Africa Acne Vulgaris Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Acne Vulgaris Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Acne Vulgaris Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Acne Vulgaris Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Acne Vulgaris Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Acne Vulgaris Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Acne Vulgaris Treatment Revenue Market Share by Region (2023-2028)
Table 6. Common Pharma Inc Corporate Information, Head Office, and Major Competitors
Table 7. Common Pharma Inc Major Business
Table 8. Common Pharma Inc Acne Vulgaris Treatment Product and Solutions
Table 9. Common Pharma Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Cutanea Life Sciences Inc Corporate Information, Head Office, and Major Competitors
Table 11. Cutanea Life Sciences Inc Major Business
Table 12. Cutanea Life Sciences Inc Acne Vulgaris Treatment Product and Solutions
Table 13. Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Dermira Inc Corporate Information, Head Office, and Major Competitors
Table 15. Dermira Inc Major Business
Table 16. Dermira Inc Acne Vulgaris Treatment Product and Solutions
Table 17. Dermira Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. ELORAC Inc Corporate Information, Head Office, and Major Competitors
Table 19. ELORAC Inc Major Business
Table 20. ELORAC Inc Acne Vulgaris Treatment Product and Solutions
Table 21. ELORAC Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Ensol Biosciences Inc Corporate Information, Head Office, and Major Competitors
Table 23. Ensol Biosciences Inc Major Business
Table 24. Ensol Biosciences Inc Acne Vulgaris Treatment Product and Solutions
Table 25. Ensol Biosciences Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Foamix Pharmaceuticals Ltd Corporate Information, Head Office, and Major Competitors
Table 27. Foamix Pharmaceuticals Ltd Major Business
Table 28. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product and Solutions
Table 29. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Galderma SA Corporate Information, Head Office, and Major Competitors
Table 31. Galderma SA Major Business
Table 32. Galderma SA Acne Vulgaris Treatment Product and Solutions
Table 33. Galderma SA Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 35. GlaxoSmithKline Plc Major Business
Table 36. GlaxoSmithKline Plc Acne Vulgaris Treatment Product and Solutions
Table 37. GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Helix BioMedix Inc Corporate Information, Head Office, and Major Competitors
Table 39. Helix BioMedix Inc Major Business
Table 40. Helix BioMedix Inc Acne Vulgaris Treatment Product and Solutions
Table 41. Helix BioMedix Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Hovione FarmaCiencia SA Corporate Information, Head Office, and Major Competitors
Table 43. Hovione FarmaCiencia SA Major Business
Table 44. Hovione FarmaCiencia SA Acne Vulgaris Treatment Product and Solutions
Table 45. Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Lee's Pharmaceutical Holdings Ltd Corporate Information, Head Office, and Major Competitors
Table 47. Lee's Pharmaceutical Holdings Ltd Major Business
Table 48. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product and Solutions
Table 49. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. LEO Pharma A/S Corporate Information, Head Office, and Major Competitors
Table 51. LEO Pharma A/S Major Business
Table 52. LEO Pharma A/S Acne Vulgaris Treatment Product and Solutions
Table 53. LEO Pharma A/S Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Novabiotics Ltd Corporate Information, Head Office, and Major Competitors
Table 55. Novabiotics Ltd Major Business
Table 56. Novabiotics Ltd Acne Vulgaris Treatment Product and Solutions
Table 57. Novabiotics Ltd Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Novan Inc Corporate Information, Head Office, and Major Competitors
Table 59. Novan Inc Major Business
Table 60. Novan Inc Acne Vulgaris Treatment Product and Solutions
Table 61. Novan Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 63. Novartis AG Major Business
Table 64. Novartis AG Acne Vulgaris Treatment Product and Solutions
Table 65. Novartis AG Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Paratek Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 67. Paratek Pharmaceuticals Inc Major Business
Table 68. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product and Solutions
Table 69. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Pfizer Inc Corporate Information, Head Office, and Major Competitors
Table 71. Pfizer Inc Major Business
Table 72. Pfizer Inc Acne Vulgaris Treatment Product and Solutions
Table 73. Pfizer Inc Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Phosphagenics Ltd Corporate Information, Head Office, and Major Competitors
Table 75. Phosphagenics Ltd Major Business
Table 76. Phosphagenics Ltd Acne Vulgaris Treatment Product and Solutions
Table 77. Phosphagenics Ltd Acne Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Global Acne Vulgaris Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 79. Global Acne Vulgaris Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 80. Breakdown of Acne Vulgaris Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Acne Vulgaris Treatment Players Head Office, Products and Services Provided
Table 82. Acne Vulgaris Treatment Mergers & Acquisitions in the Past Five Years
Table 83. Acne Vulgaris Treatment New Entrants and Expansion Plans
Table 84. Global Acne Vulgaris Treatment Revenue (USD Million) by Type (2017-2022)
Table 85. Global Acne Vulgaris Treatment Revenue Share by Type (2017-2022)
Table 86. Global Acne Vulgaris Treatment Revenue Forecast by Type (2023-2028)
Table 87. Global Acne Vulgaris Treatment Revenue by Application (2017-2022)
Table 88. Global Acne Vulgaris Treatment Revenue Forecast by Application (2023-2028)
Table 89. North America Acne Vulgaris Treatment Revenue by Type (2017-2022) & (USD Million)
Table 90. North America Acne Vulgaris Treatment Revenue by Type (2023-2028) & (USD Million)
Table 91. North America Acne Vulgaris Treatment Revenue by Application (2017-2022) & (USD Million)
Table 92. North America Acne Vulgaris Treatment Revenue by Application (2023-2028) & (USD Million)
Table 93. North America Acne Vulgaris Treatment Revenue by Country (2017-2022) & (USD Million)
Table 94. North America Acne Vulgaris Treatment Revenue by Country (2023-2028) & (USD Million)
Table 95. Europe Acne Vulgaris Treatment Revenue by Type (2017-2022) & (USD Million)
Table 96. Europe Acne Vulgaris Treatment Revenue by Type (2023-2028) & (USD Million)
Table 97. Europe Acne Vulgaris Treatment Revenue by Application (2017-2022) & (USD Million)
Table 98. Europe Acne Vulgaris Treatment Revenue by Application (2023-2028) & (USD Million)
Table 99. Europe Acne Vulgaris Treatment Revenue by Country (2017-2022) & (USD Million)
Table 100. Europe Acne Vulgaris Treatment Revenue by Country (2023-2028) & (USD Million)
Table 101. Asia-Pacific Acne Vulgaris Treatment Revenue by Type (2017-2022) & (USD Million)
Table 102. Asia-Pacific Acne Vulgaris Treatment Revenue by Type (2023-2028) & (USD Million)
Table 103. Asia-Pacific Acne Vulgaris Treatment Revenue by Application (2017-2022) & (USD Million)
Table 104. Asia-Pacific Acne Vulgaris Treatment Revenue by Application (2023-2028) & (USD Million)
Table 105. Asia-Pacific Acne Vulgaris Treatment Revenue by Region (2017-2022) & (USD Million)
Table 106. Asia-Pacific Acne Vulgaris Treatment Revenue by Region (2023-2028) & (USD Million)
Table 107. South America Acne Vulgaris Treatment Revenue by Type (2017-2022) & (USD Million)
Table 108. South America Acne Vulgaris Treatment Revenue by Type (2023-2028) & (USD Million)
Table 109. South America Acne Vulgaris Treatment Revenue by Application (2017-2022) & (USD Million)
Table 110. South America Acne Vulgaris Treatment Revenue by Application (2023-2028) & (USD Million)
Table 111. South America Acne Vulgaris Treatment Revenue by Country (2017-2022) & (USD Million)
Table 112. South America Acne Vulgaris Treatment Revenue by Country (2023-2028) & (USD Million)
Table 113. Middle East & Africa Acne Vulgaris Treatment Revenue by Type (2017-2022) & (USD Million)
Table 114. Middle East & Africa Acne Vulgaris Treatment Revenue by Type (2023-2028) & (USD Million)
Table 115. Middle East & Africa Acne Vulgaris Treatment Revenue by Application (2017-2022) & (USD Million)
Table 116. Middle East & Africa Acne Vulgaris Treatment Revenue by Application (2023-2028) & (USD Million)
Table 117. Middle East & Africa Acne Vulgaris Treatment Revenue by Country (2017-2022) & (USD Million)
Table 118. Middle East & Africa Acne Vulgaris Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Acne Vulgaris Treatment Picture
Figure 2. Global Acne Vulgaris Treatment Revenue Market Share by Type in 2021
Figure 3. CB-0601
Figure 4. CJM-112
Figure 5. CLS-007
Figure 6. Dapsone
Figure 7. DFD-10
Figure 8. DLX-2323
Figure 9. Others
Figure 10. Acne Vulgaris Treatment Revenue Market Share by Application in 2021
Figure 11. Clinic Picture
Figure 12. Hospital Picture
Figure 13. Others Picture
Figure 14. Global Acne Vulgaris Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Acne Vulgaris Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Acne Vulgaris Treatment Revenue Market Share by Region (2017-2028)
Figure 17. Global Acne Vulgaris Treatment Revenue Market Share by Region in 2021
Figure 18. North America Acne Vulgaris Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Acne Vulgaris Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Acne Vulgaris Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Acne Vulgaris Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Acne Vulgaris Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Acne Vulgaris Treatment Market Drivers
Figure 24. Acne Vulgaris Treatment Market Restraints
Figure 25. Acne Vulgaris Treatment Market Trends
Figure 26. Common Pharma Inc Recent Developments and Future Plans
Figure 27. Cutanea Life Sciences Inc Recent Developments and Future Plans
Figure 28. Dermira Inc Recent Developments and Future Plans
Figure 29. ELORAC Inc Recent Developments and Future Plans
Figure 30. Ensol Biosciences Inc Recent Developments and Future Plans
Figure 31. Foamix Pharmaceuticals Ltd Recent Developments and Future Plans
Figure 32. Galderma SA Recent Developments and Future Plans
Figure 33. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 34. Helix BioMedix Inc Recent Developments and Future Plans
Figure 35. Hovione FarmaCiencia SA Recent Developments and Future Plans
Figure 36. Lee's Pharmaceutical Holdings Ltd Recent Developments and Future Plans
Figure 37. LEO Pharma A/S Recent Developments and Future Plans
Figure 38. Novabiotics Ltd Recent Developments and Future Plans
Figure 39. Novan Inc Recent Developments and Future Plans
Figure 40. Novartis AG Recent Developments and Future Plans
Figure 41. Paratek Pharmaceuticals Inc Recent Developments and Future Plans
Figure 42. Pfizer Inc Recent Developments and Future Plans
Figure 43. Phosphagenics Ltd Recent Developments and Future Plans
Figure 44. Global Acne Vulgaris Treatment Revenue Share by Players in 2021
Figure 45. Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 46. Global Top 3 Players Acne Vulgaris Treatment Revenue Market Share in 2021
Figure 47. Global Top 10 Players Acne Vulgaris Treatment Revenue Market Share in 2021
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 49. Global Acne Vulgaris Treatment Revenue Share by Type in 2021
Figure 50. Global Acne Vulgaris Treatment Market Share Forecast by Type (2023-2028)
Figure 51. Global Acne Vulgaris Treatment Revenue Share by Application in 2021
Figure 52. Global Acne Vulgaris Treatment Market Share Forecast by Application (2023-2028)
Figure 53. North America Acne Vulgaris Treatment Sales Market Share by Type (2017-2028)
Figure 54. North America Acne Vulgaris Treatment Sales Market Share by Application (2017-2028)
Figure 55. North America Acne Vulgaris Treatment Revenue Market Share by Country (2017-2028)
Figure 56. United States Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Canada Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Mexico Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Europe Acne Vulgaris Treatment Sales Market Share by Type (2017-2028)
Figure 60. Europe Acne Vulgaris Treatment Sales Market Share by Application (2017-2028)
Figure 61. Europe Acne Vulgaris Treatment Revenue Market Share by Country (2017-2028)
Figure 62. Germany Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. France Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. United Kingdom Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Russia Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Italy Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Asia-Pacific Acne Vulgaris Treatment Sales Market Share by Type (2017-2028)
Figure 68. Asia-Pacific Acne Vulgaris Treatment Sales Market Share by Application (2017-2028)
Figure 69. Asia-Pacific Acne Vulgaris Treatment Revenue Market Share by Region (2017-2028)
Figure 70. China Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Japan Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Korea Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. India Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Southeast Asia Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Australia Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South America Acne Vulgaris Treatment Sales Market Share by Type (2017-2028)
Figure 77. South America Acne Vulgaris Treatment Sales Market Share by Application (2017-2028)
Figure 78. South America Acne Vulgaris Treatment Revenue Market Share by Country (2017-2028)
Figure 79. Brazil Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Argentina Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Middle East and Africa Acne Vulgaris Treatment Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Acne Vulgaris Treatment Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Acne Vulgaris Treatment Revenue Market Share by Country (2017-2028)
Figure 84. Turkey Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Saudi Arabia Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. UAE Acne Vulgaris Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
